Published in FEBS J on July 01, 2006
Sensing the environment: regulation of local and global homeostasis by the skin's neuroendocrine system. Adv Anat Embryol Cell Biol (2012) 2.99
Circadian genes, rhythms and the biology of mood disorders. Pharmacol Ther (2007) 2.62
Agomelatine, the first melatonergic antidepressant: discovery, characterization and development. Nat Rev Drug Discov (2010) 1.47
A role for the circadian genes in drug addiction. Neuropharmacology (2008) 1.32
Circadian photoreception: ageing and the eye's important role in systemic health. Br J Ophthalmol (2008) 1.30
Kinetic, thermodynamic and X-ray structural insights into the interaction of melatonin and analogues with quinone reductase 2. Biochem J (2008) 1.13
Urban-like night illumination reduces melatonin release in European blackbirds (Turdus merula): implications of city life for biological time-keeping of songbirds. Front Zool (2013) 1.10
Sirtuins, melatonin and circadian rhythms: building a bridge between aging and cancer. J Pineal Res (2010) 1.02
The mode of action of thidiazuron: auxins, indoleamines, and ion channels in the regeneration of Echinacea purpurea L. Plant Cell Rep (2007) 1.00
Exacerbated mechanical allodynia in rats with depression-like behavior. Brain Res (2008) 0.98
Melatonin in aging and disease -multiple consequences of reduced secretion, options and limits of treatment. Aging Dis (2011) 0.92
Delayed onset of the diurnal melatonin rise in patients with Huntington's disease. J Neurol (2009) 0.91
Disruption of circadian rhythms: a crucial factor in the etiology of depression. Depress Res Treat (2011) 0.90
Therapeutic potential of melatonin and its analogs in Parkinson's disease: focus on sleep and neuroprotection. Ther Adv Neurol Disord (2011) 0.90
Integrated text mining and chemoinformatics analysis associates diet to health benefit at molecular level. PLoS Comput Biol (2014) 0.89
New approaches in the management of insomnia: weighing the advantages of prolonged-release melatonin and synthetic melatoninergic agonists. Neuropsychiatr Dis Treat (2009) 0.89
Neurobiology, pathophysiology, and treatment of melatonin deficiency and dysfunction. ScientificWorldJournal (2012) 0.89
Melatonin in antinociception: its therapeutic applications. Curr Neuropharmacol (2012) 0.89
Melatonin in children with autism spectrum disorders: endogenous and pharmacokinetic profiles in relation to sleep. J Autism Dev Disord (2014) 0.88
Plant neurobiology: from sensory biology, via plant communication, to social plant behavior. Cogn Process (2008) 0.88
Critical appraisal and update on the clinical utility of agomelatine, a melatonergic agonist, for the treatment of major depressive disease in adults. Neuropsychiatr Dis Treat (2009) 0.88
Melatonin the "light of night" in human biology and adolescent idiopathic scoliosis. Scoliosis (2007) 0.88
Hepatoprotective actions of melatonin: possible mediation by melatonin receptors. World J Gastroenterol (2010) 0.87
Urinary 6-sulfatoxymelatonin level in age-related macular degeneration patients. Mol Vis (2009) 0.86
Melatonin metabolism in the central nervous system. Curr Neuropharmacol (2010) 0.86
Measurement of melatonin in alcoholic and hot water extracts of Tanacetum parthenium, Tripleurospermum disciforme and Viola odorata. Daru (2010) 0.86
Exacerbated mechanical hyperalgesia in rats with genetically predisposed depressive behavior: role of melatonin and NMDA receptors. Pain (2012) 0.85
A combined effect of dextromethorphan and melatonin on neuropathic pain behavior in rats. Brain Res (2009) 0.85
Pancreatic stellate/myofibroblast cells express G-protein-coupled melatonin receptor 1. Wien Med Wochenschr (2008) 0.84
Abnormal response of the proliferation and differentiation of growth plate chondrocytes to melatonin in adolescent idiopathic scoliosis. Int J Mol Sci (2014) 0.84
Melatonin improves bladder symptoms and may ameliorate bladder damage via increasing HO-1 in rats. Inflammation (2013) 0.84
Effects of melatonin and its receptor antagonist on retinal pigment epithelial cells against hydrogen peroxide damage. Mol Vis (2012) 0.84
Chronobiology of Melatonin beyond the Feedback to the Suprachiasmatic Nucleus-Consequences to Melatonin Dysfunction. Int J Mol Sci (2013) 0.83
Long-term melatonin administration attenuates low-LET gamma-radiation-induced lymphatic tissue injury during the reproductively active and inactive phases of Indian palm squirrels (Funambulus pennanti). Br J Radiol (2010) 0.83
Melatonin--a pleiotropic molecule involved in pathophysiological processes following organ transplantation. Immunology (2009) 0.83
Light as Therapy for Sleep Disorders and Depression in Older Adults. Clin Geriatr (2008) 0.83
Abnormal Skeletal Growth in Adolescent Idiopathic Scoliosis Is Associated with Abnormal Quantitative Expression of Melatonin Receptor, MT2. Int J Mol Sci (2013) 0.83
Melatonin in perioperative medicine: Current perspective. Saudi J Anaesth (2013) 0.82
Melatonin promotes angiogenesis during repair of bone defects: a radiological and histomorphometric study in rabbit tibiae. Clin Oral Investig (2012) 0.82
Chloroplast-encoded serotonin N-acetyltransferase in the red alga Pyropia yezoensis: gene transition to the nucleus from chloroplasts. J Exp Bot (2014) 0.82
Meditation and its regulatory role on sleep. Front Neurol (2012) 0.81
New targets for rapid antidepressant action. Prog Neurobiol (2015) 0.81
Stress and Its Effects on Glucose Metabolism and 11β-HSD Activities in Rats Fed on a Combination of High-Fat and High-Sucrose Diet with Glycyrrhizic Acid. J Diabetes Res (2013) 0.81
The circadian control of skin and cutaneous photodamage. Photochem Photobiol (2012) 0.81
Melatonin in Children with Autism Spectrum Disorders: How Does the Evidence Fit Together? J Nat Sci (2015) 0.80
Lipids around the Clock: Focus on Circadian Rhythms and Lipid Metabolism. Biology (Basel) (2015) 0.80
Circadian System and Melatonin Hormone: Risk Factors for Complications during Pregnancy. Obstet Gynecol Int (2015) 0.80
Agomelatine beyond borders: current evidences of its efficacy in disorders other than major depression. Int J Mol Sci (2015) 0.79
Expression of the G protein gammaT1 subunit during zebrafish development. Gene Expr Patterns (2007) 0.79
Chrononutrition against oxidative stress in aging. Oxid Med Cell Longev (2013) 0.79
Potency of melatonin in living beings. Balsaenggwa Saengsig (2013) 0.79
Serum melatonin levels in ankylosing spondilitis: correlation with disease activity. Rheumatol Int (2009) 0.78
The pattern of melatonin receptor expression in the brain may influence antidepressant treatment. Med Hypotheses (2007) 0.78
Melatonin plays a protective role in postburn rodent gut pathophysiology. Int J Biol Sci (2010) 0.78
Relationship between Oxidative Stress, Circadian Rhythms, and AMD. Oxid Med Cell Longev (2015) 0.78
New evidence for cross talk between melatonin and mitochondria mediated by a circadian-compatible interaction with nitric oxide. Int J Mol Sci (2013) 0.78
Melatonin Reverses Fas, E2F-1 and Endoplasmic Reticulum Stress Mediated Apoptosis and Dysregulation of Autophagy Induced by the Herbicide Atrazine in Murine Splenocytes. PLoS One (2014) 0.78
Biological rhythms and mood disorders. Dialogues Clin Neurosci (2012) 0.78
Therapeutic actions of melatonin on gastrointestinal cancer development and progression. Transl Gastrointest Cancer (2013) 0.78
Dietary correlates of urinary 6-sulfatoxymelatonin concentrations in the Nurses' Health Study cohorts. Am J Clin Nutr (2009) 0.78
Melatonin, the Hormone of Darkness: From Sleep Promotion to Ebola Treatment. Brain Disord Ther (2015) 0.78
A molecular and chemical perspective in defining melatonin receptor subtype selectivity. Int J Mol Sci (2013) 0.77
Melatonin: Pharmacology, Functions and Therapeutic Benefits. Curr Neuropharmacol (2017) 0.77
The effect of melatonin on plasma markers of inflammation and on expression of nuclear factor-kappa beta in acetic acid-induced colitis in the rat. Dig Dis Sci (2013) 0.77
Reduction of Melatonin Level in Patients with Type II Diabetes and Periodontal Diseases. J Dent Res Dent Clin Dent Prospects (2014) 0.77
Melatonin and its agonist ramelteon in Alzheimer's disease: possible therapeutic value. Int J Alzheimers Dis (2010) 0.77
Neuroprotective therapies after perinatal hypoxic-ischemic brain injury. Brain Sci (2013) 0.77
Melatonin signaling and its modulation of PfNF-YB transcription factor expression in Plasmodium falciparum. Int J Mol Sci (2013) 0.77
Clinical pharmacology of melatonin in the treatment of tinnitus: a review. Eur J Clin Pharmacol (2015) 0.77
Melatonin in Chronic Pain Syndromes. Pain Ther (2016) 0.76
Melatonin, noncoding RNAs, messenger RNA stability and epigenetics--evidence, hints, gaps and perspectives. Int J Mol Sci (2014) 0.76
Influence of Melatonin on the Proliferative and Apoptotic Responses of the Prostate under Normal and Hyperglycemic Conditions. J Diabetes Res (2015) 0.76
Impact of light/dark cycle patterns on oxidative stress in an adriamycin-induced nephropathy model in rats. PLoS One (2014) 0.76
Milk Collected at Night Induces Sedative and Anxiolytic-Like Effects and Augments Pentobarbital-Induced Sleeping Behavior in Mice. J Med Food (2015) 0.76
Homology models of melatonin receptors: challenges and recent advances. Int J Mol Sci (2013) 0.76
Persistent polar depletion of stratospheric ozone and emergent mechanisms of ultraviolet radiation-mediated health dysregulation. Rev Environ Health (2012) 0.76
Day and Night GSH and MDA Levels in Healthy Adults and Effects of Different Doses of Melatonin on These Parameters. Int J Cell Biol (2011) 0.76
Urinary 6-sulphatoxymelatonin levels in patients with senile cataracts. BMC Ophthalmol (2013) 0.75
Effect of melatonin on duration of delirium in organophosphorus compound poisoning patients: A double-blind randomised placebo controlled trial. Indian J Anaesth (2016) 0.75
Cadmium-Induced Disruption in 24-h Expression of Clock and Redox Enzyme Genes in Rat Medial Basal Hypothalamus: Prevention by Melatonin. Front Neurol (2011) 0.75
Sleep Disorders in Postmenopausal Women. J Sleep Disord Ther (2015) 0.75
Associations of sleep duration with open angle glaucoma in the Korea national health and nutrition examination survey. Medicine (Baltimore) (2016) 0.75
Melatonin MT₁ and MT₂ Receptors in the Ram Reproductive Tract. Int J Mol Sci (2017) 0.75
The Effect of Melatonin on Climacteric Symptoms in Menopausal Women; A Double-Blind, Randomized Controlled, Clinical Trial. Iran J Public Health (2014) 0.75
Circadian Rhythms and Hormonal Homeostasis: Pathophysiological Implications. Biology (Basel) (2017) 0.75
Daily melatonin levels in women with systemic lupus erythematosus. Balkan Med J (2015) 0.75
Preliminary study: Evaluation of melatonin secretion in children and adolescents with type 1 diabetes mellitus. Indian J Endocrinol Metab (2014) 0.75
Circadian Rhythm Regulates Development of Enamel in Mouse Mandibular First Molar. PLoS One (2016) 0.75
Lung, gastric and colorectal cancer mortality by occupation and industry among working-aged men in Japan. Sci Rep (2017) 0.75
Associations of common chronic non-communicable diseases and medical conditions with sleep-related problems in a population-based health examination study. Sleep Sci (2016) 0.75
Diagnostic accuracy of susceptibility-weighted magnetic resonance imaging for the evaluation of pineal gland calcification. PLoS One (2017) 0.75
Constant illumination reduces circulating melatonin and impairs immune function in the cricket Teleogryllus commodus. PeerJ (2015) 0.75
Melatonin in the mammalian olfactory bulb. Neuroscience (2013) 0.75
Can the morning serum melatonin values reflect inflammatory activity: a biochemical evaluation? Rheumatol Int (2014) 0.75
Ultradian oscillation in expression of four melatonin receptor subtype genes in the pineal gland of the grass puffer, a semilunar-synchronized spawner, under constant darkness. Front Neurosci (2015) 0.75
Urinary 6-sulfatoxymelatonin level in diabetic retinopathy patients with type 2 diabetes. Int J Clin Exp Pathol (2014) 0.75
Assessing the Dim Light Melatonin Onset in Adults with Autism Spectrum Disorder and No Comorbid Intellectual Disability. J Autism Dev Disord (2017) 0.75
Polysomnographic findings in craniopharyngioma patients. Sleep Breath (2017) 0.75
Sleep, Melatonin, and the Menopausal Transition: What Are the Links? Sleep Sci (2017) 0.75
The influence of intermittent fasting on the circadian pattern of melatonin while controlling for caloric intake, energy expenditure, light exposure, and sleep schedules: A preliminary report. Ann Thorac Med (2017) 0.75
The effect of electrical stimulation and high potassium concentrations on the efflux of (3H) gamma-aminobutyric acid from brain slices. J Neurochem (1969) 3.05
Epidemiological studies in medical practice pose practical challenges in developing countries--a situational analysis. J Assoc Physicians India (1999) 2.00
Automated phase-measuring profilometry of 3-D diffuse objects. Appl Opt (1984) 1.60
The release of gamma-aminobutyric acid during inhibition in the cat visual cortex. J Physiol (1971) 1.59
Species differences in the diurnal rhythmicity of courtship behaviour within the melanogaster group of the genus Drosophila. Anim Behav (1972) 1.56
Strain engineering and one-dimensional organization of metal-insulator domains in single-crystal vanadium dioxide beams. Nat Nanotechnol (2009) 1.49
A review of the evidence supporting melatonin's role as an antioxidant. J Pineal Res (1995) 1.36
Real-time measurement of stress and damage evolution during initial lithiation of crystalline silicon. Phys Rev Lett (2011) 1.29
Detection and quantification of the antioxidant melatonin in Montmorency and Balaton tart cherries (Prunus cerasus). J Agric Food Chem (2001) 1.16
Melatonin and sleep in aging population. Exp Gerontol (2005) 1.11
The significance of the metabolism of the neurohormone melatonin: antioxidative protection and formation of bioactive substances. Neurosci Biobehav Rev (1993) 1.10
Twenty-four-hour rhythms in immune responses in rat submaxillary lymph nodes and spleen: effect of cyclosporine. Brain Behav Immun (1996) 1.09
Potent neuroprotective properties against the Alzheimer beta-amyloid by an endogenous melatonin-related indole structure, indole-3-propionic acid. J Biol Chem (1999) 1.07
An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease. J Neural Transm (Vienna) (2000) 1.04
Circadian melatonin and cortisol levels in rheumatoid arthritis patients in winter time: a north and south Europe comparison. Ann Rheum Dis (2005) 1.04
Melatonin stimulates brain glutathione peroxidase activity. Neurochem Int (1995) 1.04
N1-acetyl-N2-formyl-5-methoxykynuramine, a biogenic amine and melatonin metabolite, functions as a potent antioxidant. FASEB J (2001) 1.03
Chronomics, neuroendocrine feedsidewards and the recording and consulting of nowcasts--forecasts of geomagnetics. Biomed Pharmacother (2005) 1.03
Effect of tryptophan administration on circulating melatonin levels in chicks and rats: evidence for stimulation of melatonin synthesis and release in the gastrointestinal tract. Life Sci (1992) 1.02
Papillary fibroelastoma of aortic and mitral valves following myectomy for idiopathic hypertrophic subaortic stenosis. Thorac Cardiovasc Surg (1981) 1.02
Melatonin serum levels in rheumatoid arthritis. Ann N Y Acad Sci (2002) 1.02
Liposarcoma of the ileum with secondaries in the liver. Am J Gastroenterol (1972) 1.01
Melatonin in Alzheimer's disease and other neurodegenerative disorders. Behav Brain Funct (2006) 1.01
Solitary osteochondroma causing spinal cord compression. Int Surg (1976) 1.00
The melatonin-cytokine connection in rheumatoid arthritis. Ann Rheum Dis (2005) 0.99
Evaluation of the antioxidant activity of melatonin in vitro. Free Radic Biol Med (1996) 0.99
The release of 3H-gamma-aminobutyric acid (GABA) from rat cerebral cortex. Br J Pharmacol (1968) 0.99
Endoplasmic reticulum (ER) stress & diabetes. Indian J Med Res (2007) 0.98
Melatonin as a free radical scavenger: implications for aging and age-related diseases. Ann N Y Acad Sci (1994) 0.98
Quantitative description of the effect of molecular size upon electroosmotic flux enhancement during iontophoresis for a synthetic membrane and human epidermal membrane. J Pharm Sci (1996) 0.98
Intraluminal pulmonary artery fibroma in a 7-year-old boy. Pediatr Cardiol (2000) 0.98
Cardiovascular tests of autonomic function and sympathetic skin responses in patients with major depression. J Neurol Neurosurg Psychiatry (1995) 0.98
Is there life after Buckley's formocresol? Part II - Development of a protocol for the management of extensive caries in the primary molar. Int J Paediatr Dent (2006) 0.97
Chronomics: circadian lead of extrapineal vs. pineal melatonin rhythms with an infradian hypothalamic exploration. Biomed Pharmacother (2005) 0.97
Possible therapeutic value of melatonin in mild cognitive impairment: a retrospective study. J Pineal Res (2007) 0.97
Encrustation of catheter materials in vitro. J Urol (1972) 0.95
Preferential radiation sensitization of prostate cancer in nude mice by nutraceutical antioxidant gamma-tocotrienol. Life Sci (2006) 0.95
On the primary functions of melatonin in evolution: mediation of photoperiodic signals in a unicell, photooxidation, and scavenging of free radicals. J Pineal Res (1995) 0.94
Planning and implementing a program of renovations of emergency obstetric care facilities: experiences in Rajasthan, India. Int J Gynaecol Obstet (2002) 0.94
Melatonin, immune function and aging. Immun Ageing (2005) 0.93
Time-dependent melatonin analgesia in mice: inhibition by opiate or benzodiazepine antagonism. Eur J Pharmacol (1991) 0.93
Nuclear localization of melatonin in different mammalian tissues: immunocytochemical and radioimmunoassay evidence. J Cell Biochem (1993) 0.93
Role of melatonin in neurodegenerative diseases. Neurotox Res (2005) 0.93
Experimental allergic encephalomyelitis in male Lewis rats subjected to calorie restriction. J Physiol Biochem (2004) 0.93
Radioprotection by metals: selenium. Adv Space Res (1992) 0.92
Cationic antiprotozoal drugs. Trypanocidal activity of 2-(4'-formylphenyl)imidazo[1,2-a]pyridinium guanylhydrazones and related derivatives of quaternary heteroaromatic compounds. J Med Chem (1990) 0.92
Photoperiodism and effects of indoleamines in a unicellular alga, Gonyaulax polyedra. Science (1991) 0.92
Short-term incorporation of organic manures and biofertilizers influences biochemical and microbial characteristics of soils under an annual crop [Turmeric (Curcuma longa L.)]. Bioresour Technol (2010) 0.92
A study on staging bone scans in newly diagnosed prostate cancer. Urol Int (2006) 0.91
The effect of stimulation of inhibitory pathways on the release of endogenous gamma-aminobutyric acid from the rat cerebral cortex. Br J Pharmacol (1970) 0.91
Indole-3-propionate: a potent hydroxyl radical scavenger in rat brain. Brain Res (1999) 0.90
On the genetics of a circadian rhythm in Drosophila. Experientia (1968) 0.90
Effect of nesiritide on renal function in patients admitted for decompensated heart failure. QJM (2007) 0.90
Melatonin immunoreactivity in the photosynthetic prokaryote Rhodospirillum rubrum: implications for an ancient antioxidant system. Cell Mol Biol Res (1995) 0.90
Melatonin, environmental light, and breast cancer. Breast Cancer Res Treat (2007) 0.89
Chronomics affirm extending scope of lead in phase of duodenal vs. pineal circadian melatonin rhythms. Biomed Pharmacother (2005) 0.89
Eye protection in ear, nose and throat surgery. J Laryngol Otol (1993) 0.88
Evaluation of extracorporeal shock wave therapy in Peyronie's disease. Urology (2002) 0.88
Melatonin in the eye: implications for glaucoma. Exp Eye Res (2006) 0.88
Lymphoid tumours and breast cancer in ataxia telangiectasia; substantial protective effect of residual ATM kinase activity against childhood tumours. Br J Cancer (2011) 0.87
Severe reaction to radiotherapy for breast cancer as the presenting feature of ataxia telangiectasia. Br J Cancer (2011) 0.87
Retinal localization of the hydroxyindole-O-methyl transferase (HIOMT) in the rat. Endocrinology (1971) 0.86
Indole-3-pyruvic and -propionic acids, kynurenic acid, and related metabolites as luminophores and free-radical scavengers. Adv Exp Med Biol (1999) 0.86
Effect of removal of epididymal fat on spermatogenesis in albino rats. Indian J Exp Biol (1986) 0.86
Ascorbic acid levels in blood during tetracycline administration. J Indian Med Assoc (1968) 0.86
Melatonin in rheumatoid arthritis: a disease-promoting and modulating hormone? Clin Exp Rheumatol (2003) 0.86
Cyclic-3-hydroxymelatonin (C3HOM), a potent antioxidant, scavenges free radicals and suppresses oxidative reactions. Curr Med Chem (2014) 0.86
Gonadal steroids as modulators of the function of the pineal gland. Gen Comp Endocrinol (1975) 0.85
The release of amino-acids from electrically stimulated rat cerebral cortex slices. Br J Pharmacol (1969) 0.85
Circadian oscillation in rat liver tryptophan pyrrolase and its analysis by substrate and hormone induction. Nature (1968) 0.85
Melatonin increases in vivo GABA accumulation in rat hypothalamus, cerebellum, cerebral cortex and pineal gland. Brain Res (1986) 0.85
Which is the real gold standard for small-volume renal tumors? Radical nephrectomy versus nephron-sparing surgery. J Endourol (2004) 0.85
Mechanism of radioprotection by δ-tocotrienol: pharmacokinetics, pharmacodynamics and modulation of signalling pathways. Br J Radiol (2012) 0.85
Application of the threshold of toxicological concern approach for the safety evaluation of calendula flower (Calendula officinalis) petals and extracts used in cosmetic and personal care products. Food Chem Toxicol (2009) 0.85
Monozygotic twins with Alzheimer's disease treated with melatonin: Case report. J Pineal Res (1998) 0.84
Twenty-four hour urinary excretion of 6-hydroxymelatonin sulfate in Down syndrome subjects. J Pineal Res (1996) 0.84
Melatonin effects on behavior: possible mediation by the central GABAergic system. Neurosci Biobehav Rev (1996) 0.84
Melatonin treatment improves the antioxidant status and decreases lipid content in brain and liver of rats. Eur J Pharmacol (2007) 0.84
Effect of melatonin in selected populations of sleep-disturbed patients. Biol Signals Recept (1999) 0.84
Effects of neonatal clomipramine treatment on locomotor activity, anxiety-related behavior and serotonin turnover in Syrian hamsters. Neuropsychobiology (1999) 0.84
Effects of lysergic acid diethylamide on autonomic post-ganglionic transmission. J Physiol (1975) 0.84
Interferon-gamma release in sympathetically denervated rat submaxillary lymph nodes. Neuroimmunomodulation (2000) 0.84
Acute superior cervical ganglionectomy depresses the postcastration rise of gonadotropins in male rats. Brain Res (1984) 0.83
Melatonin blocks in vitro generation of prostaglandin by the uterus and hypothalamus. Eur J Pharmacol (1980) 0.83
Lipoprotein (a): role in diabetes and its vascular complications. J Assoc Physicians India (2001) 0.83
DNA oxidatively damaged by chromium(III) and H(2)O(2) is protected by the antioxidants melatonin, N(1)-acetyl-N(2)-formyl-5-methoxykynuramine, resveratrol and uric acid. Int J Biochem Cell Biol (2001) 0.83
Migration of human granulocytes through reconstituted basement membrane is not dependent on matrix metalloproteinase-9 (MMP-9). J Neuroimmunol (2001) 0.83
Melatonin as an anxiolytic in rats: time dependence and interaction with the central GABAergic system. Eur J Pharmacol (1993) 0.83
Alzheimer beta protein mediated oxidative damage of mitochondrial DNA: prevention by melatonin. J Pineal Res (1999) 0.83
Binding of melatonin to human and rat plasma proteins. Endocrinology (1972) 0.83
Porphyric enzymes in hamster Harderian gland, a model of damage by porphyrins and their precursors. A chronobiological study on the role of sex differences. Chem Biol Interact (2001) 0.83
Assessing trends in HIV risk behaviors in Asia. AIDS (1998) 0.83